Wong, C. H., Ma, B. B. Y., Cheong, H. T., Hui, C. W. C., Hui, E. P., & Chan, A. T. C. (2015). Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC). Am J Cancer Res.

Wong, Chi Hang, Brigette Buig Yue Ma, Hio Teng Cheong, Connie Wun Chun Hui, Edwin Pun Hui, a Anthony Tak Cheung Chan. "Preclinical Evaluation of PI3K Inhibitor BYL719 As a Single Agent and Its Synergism in Combination With Cisplatin or MEK Inhibitor in Nasopharyngeal Carcinoma (NPC)." Am J Cancer Res 2015.

Wong, Chi Hang, et al. "Preclinical Evaluation of PI3K Inhibitor BYL719 As a Single Agent and Its Synergism in Combination With Cisplatin or MEK Inhibitor in Nasopharyngeal Carcinoma (NPC)." Am J Cancer Res 2015.